Pasithea Therapeutics (KTTA) Other Non-Current Liabilities (2021 - 2024)
Historic Other Non-Current Liabilities for Pasithea Therapeutics (KTTA) over the last 4 years, with Q3 2024 value amounting to $163578.0.
- Pasithea Therapeutics' Other Non-Current Liabilities rose 46291.68% to $163578.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $163578.0, marking a year-over-year increase of 46291.68%. This contributed to the annual value of $84366.0 for FY2023, which is 4000.04% down from last year.
- Per Pasithea Therapeutics' latest filing, its Other Non-Current Liabilities stood at $163578.0 for Q3 2024, which was up 46291.68% from $93272.0 recorded in Q2 2024.
- Over the past 5 years, Pasithea Therapeutics' Other Non-Current Liabilities peaked at $4.0 million during Q3 2021, and registered a low of $29059.0 during Q3 2023.
- In the last 4 years, Pasithea Therapeutics' Other Non-Current Liabilities had a median value of $163578.0 in 2024 and averaged $601269.1.
- Per our database at Business Quant, Pasithea Therapeutics' Other Non-Current Liabilities plummeted by 9499.95% in 2023 and then soared by 46291.68% in 2024.
- Pasithea Therapeutics' Other Non-Current Liabilities (Quarter) stood at $1.5 million in 2021, then tumbled by 90.32% to $140611.0 in 2022, then tumbled by 40.0% to $84366.0 in 2023, then skyrocketed by 93.89% to $163578.0 in 2024.
- Its Other Non-Current Liabilities stands at $163578.0 for Q3 2024, versus $93272.0 for Q2 2024 and $57650.0 for Q1 2024.